Back
Incyte Stock Price Chart
Sponsored
INCY
Sponsored
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!
Buy
64
INCY
Incyte
Last Price:
77.29
Seasonality Move:
35.45%
7 Day Trial
ALL ACCESS PASS
$
7
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and INCY is experiencing buying pressure, which is a positive indicator for future bullish movement.
Incyte Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 72.7 | Buy |
20-day SMA: | 68.51 | Buy |
50-day SMA: | 66.46 | Buy |
200-day SMA: | 60.94 | Buy |
8-day EMA: | 73.42 | Buy |
20-day EMA: | 70.01 | Buy |
50-day EMA: | 67.15 | Buy |
200-day EMA: | 63.04 | Buy |
Incyte Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.72 | Buy |
Relative Strength Index (14 RSI): | 80.26 | Buy |
Chaikin Money Flow: | 1140547 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (64.25 - 72.25) | Buy |
Bollinger Bands (100): | (61.18 - 68.26) | Buy |
Incyte Technical Analysis
Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Incyte Stock
Is Incyte Stock a Buy?
- Incyte share price is 77.28 while INCY 8-day simple moving average is 72.70, which is a Buy signal.
- The stock price of INCY is 77.28 while Incyte 20-day SMA is 68.51, which makes it a Buy.
- Incyte 50-day simple moving average is 66.46 while INCY share price is 77.28, making it a Buy technically.
- INCY stock price is 77.28 and Incyte 200-day simple moving average is 60.94, creating a Buy signal.
INCY Technical Analysis vs Fundamental Analysis
Incyte Stock Info
Market Cap:
14.89B
Price in USD:
77.28
Share Volume:
1.25M
Incyte 52-Week Range
52-Week High:
77.37
52-Week Low:
50.35
Buy
64
Incyte (INCY)
is a Buy
Incyte Share Price Forecast
-
What is the Incyte stock price today?
The Incyte stock price is 77.28 USD today. -
Will INCY stock go up or go down?
Incyte> share price is forecast to RISE/FALL based on technical indicators -
Is Incyte overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Incyte is not overvalued.
Is Incyte Stock a Buy?
- Incyte share price is 77.28 while INCY 8-day exponential moving average is 73.42, which is a Buy signal.
- The stock price of INCY is 77.28 while Incyte 20-day EMA is 70.01, which makes it a Buy.
- Incyte 50-day exponential moving average is 67.15 while INCY share price is 77.28, making it a Buy technically.
- INCY stock price is 77.28 and Incyte 200-day simple moving average is 63.04, creating a Buy signal.
Fundamental Analysis of Incyte
Is Incyte a good investment?
- Analysts estimate an earnings decrease this quarter of $0.47 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.29 per share, and an increase next year of $4.72 per share.
Technical Analysis of Incyte
Should I short Incyte stock?
- INCY Moving Average Covergence Divergence (MACD) indicator is 2.72, suggesting Incyte is a Buy
- Incyte Relative Strength Index (RSI) is 80.26, which suggest Incyte is overbought
- The Bollinger Bands (25) for Incyte is (64.25 - 72.25), which suggest Incyte is a Buy
- The Bollinger Bands (100) for Incyte is (61.18 - 68.26), which suggest Incyte is a Buy
* Incyte stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.